{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T06:08:33Z","timestamp":1783922913238,"version":"3.55.0"},"reference-count":156,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.bcp.2026.118115","type":"journal-article","created":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T15:20:40Z","timestamp":1780154440000},"page":"118115","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P1","title":["Therapeutic development for hypertension by targeting the peptide-mediated blood pressure control"],"prefix":"10.1016","volume":"251","author":[{"given":"Akira","family":"Sato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6750-1668","authenticated-orcid":false,"given":"Hisakazu","family":"Ogita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2026.118115_b0005","first-page":"341","article-title":"Integration and control of circulatory function","volume":"9","author":"Guyton","year":"1976","journal-title":"Int. Rev. Physiol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118115_b0010","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1152\/physrev.00041.2022","article-title":"Sex differences in blood pressure regulation and hypertension: renal, hemodynamic, and hormonal mechanisms","volume":"104","author":"Drury","year":"2024","journal-title":"Physiol. Rev."},{"issue":"5014","key":"10.1016\/j.bcp.2026.118115_b0015","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1126\/science.2063193","article-title":"Blood pressure control\u2013special role of the kidneys and body fluids","volume":"252","author":"Guyton","year":"1991","journal-title":"Science"},{"issue":"Suppl4","key":"10.1016\/j.bcp.2026.118115_b0020","first-page":"S281","article-title":"Neuro-endocrine regulation of blood pressure","author":"Chopra","year":"2011","journal-title":"Indian J. Endocrinol. Metab. 15"},{"issue":"2","key":"10.1016\/j.bcp.2026.118115_b0025","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1056\/NEJMra1509723","article-title":"Baroreflex Dysfunction","volume":"382","author":"Kaufmann","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.bcp.2026.118115_b0030","first-page":"RA1-8","article-title":"Arterial baroreceptors in the management of systemic hypertension","volume":"16","author":"Kougias","year":"2010","journal-title":"Med. Sci. Monit."},{"issue":"5","key":"10.1016\/j.bcp.2026.118115_b0035","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s00424-024-02908-1","article-title":"The renin angiotensin aldosterone system","volume":"476","author":"Triebel","year":"2024","journal-title":"Pflugers Arch."},{"issue":"2","key":"10.1016\/j.bcp.2026.118115_b0040","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/jvim.15454","article-title":"The renin-angiotensin-aldosterone system and its suppression","volume":"33","author":"Ames","year":"2019","journal-title":"J. Vet. Intern. Med."},{"issue":"4","key":"10.1016\/j.bcp.2026.118115_b0045","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.jacc.2006.05.045","article-title":"Effects of normal, pre-hypertensive, and hypertensive blood pressure levels on progression of coronary atherosclerosis","volume":"48","author":"Sipahi","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"issue":"6","key":"10.1016\/j.bcp.2026.118115_b0050","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.bja.2021.06.048","article-title":"Heterogeneous impact of hypotension on organ perfusion and outcomes: a narrative review","volume":"127","author":"Meng","year":"2021","journal-title":"Br. J. Anaesth."},{"issue":"1","key":"10.1016\/j.bcp.2026.118115_b0055","first-page":"55","article-title":"Shock: a review of pathophysiology and management","volume":"2","author":"Worthley","year":"2000","journal-title":"Part i, Crit Care Resusc"},{"issue":"12","key":"10.1016\/j.bcp.2026.118115_b0060","first-page":"1","article-title":"Evaluation and management of hypotensive patients in the emergency department","volume":"25","author":"Srica","year":"2023","journal-title":"Emerg. Med. Pract."},{"key":"10.1016\/j.bcp.2026.118115_b0065","doi-asserted-by":"crossref","unstructured":"D.W. Jones, K.C. Ferdinand, S.J. Taler, H.M. Johnson, D. Shimbo, M. Abdalla, M.M. Altieri, N. Bansal, N.A. Bello, A.P. Bress, J. Carter, J.B. Cohen, K.J. Collins, Y. Commodore-Mensah, L.L. Davis, B. Egan, S.S. Khan, D.M. Lloyd-Jones, B.M. Melnyk, ..., W.C. Members*, 2025 AHA\/ACC\/AANP\/AAPA\/ABC\/ACCP\/ACPM\/AGS\/AMA\/ASPC\/NMA\/PCNA\/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines, Circulation 152(11) (2025) e114-e218.","DOI":"10.1161\/CIR.0000000000001356"},{"issue":"1","key":"10.1016\/j.bcp.2026.118115_b0070","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01913-2018","article-title":"Haemodynamic definitions and updated clinical classification of pulmonary hypertension","volume":"53","author":"Simonneau","year":"2019","journal-title":"Eur. Respir. J."},{"issue":"9587","key":"10.1016\/j.bcp.2026.118115_b0075","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0140-6736(07)61299-9","article-title":"Essential hypertension","volume":"370","author":"Messerli","year":"2007","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.bcp.2026.118115_b0080","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.jacc.2018.07.008","article-title":"Prevention and control of hypertension: JACC health promotion series","volume":"72","author":"Carey","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"issue":"40","key":"10.1016\/j.bcp.2026.118115_b0085","doi-asserted-by":"crossref","first-page":"6111","DOI":"10.3748\/wjg.v26.i40.6111","article-title":"Cirrhotic portal hypertension: from pathophysiology to novel therapeutics","volume":"26","author":"Gunarathne","year":"2020","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.bcp.2026.118115_b0090","doi-asserted-by":"crossref","unstructured":"R.M. Carey, D.A. Calhoun, G.L. Bakris, R.D. Brook, S.L. Daugherty, C.R. Dennison-Himmelfarb, B.M. Egan, J.M. Flack, S.S. Gidding, E. Judd, D.T. Lackland, C.L. Laffer, C. Newton-Cheh, S.M. Smith, S.J. Taler, S.C. Textor, T.N. Turan, W.B. White, A.H.A.P.P.E.a.P.C.o.t.C.o. Hypertension, ..., a.S. Council, Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association, Hypertension 72(5) (2018) e53-e90.","DOI":"10.1161\/HYP.0000000000000084"},{"key":"10.1016\/j.bcp.2026.118115_b0095","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-079108","article-title":"Diagnosis and management of resistant hypertension","volume":"385","author":"Schiffrin","year":"2024","journal-title":"BMJ"},{"issue":"7","key":"10.1016\/j.bcp.2026.118115_b0100","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1161\/ATVBAHA.118.311282","article-title":"Renin-angiotensin system and cardiovascular functions","volume":"38","author":"Wu","year":"2018","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"2","key":"10.1016\/j.bcp.2026.118115_b0105","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1124\/pr.115.011833","article-title":"Endothelin","volume":"68","author":"Davenport","year":"2016","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bcp.2026.118115_b0110","doi-asserted-by":"crossref","unstructured":"L.R. Potter, A.R. Yoder, D.R. Flora, L.K. Antos, D.M. Dickey, Natriuretic peptides: their structures, receptors, physiologic functions and therapeutic applications, Handb Exp Pharmacol (191) (2009) 341-366.","DOI":"10.1007\/978-3-540-68964-5_15"},{"issue":"6","key":"10.1016\/j.bcp.2026.118115_b0115","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/s41371-021-00534-3","article-title":"Epidemiology and control of hypertension in Japan: a comparison with Western countries","volume":"38","author":"Hisamatsu","year":"2024","journal-title":"J. Hum. Hypertens."},{"issue":"1","key":"10.1016\/j.bcp.2026.118115_b0120","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s41392-022-00904-4","article-title":"Therapeutic peptides: current applications and future directions","volume":"7","author":"Wang","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.bcp.2026.118115_b0125","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.drudis.2014.10.003","article-title":"Peptide therapeutics: current status and future directions","volume":"20","author":"Fosgerau","year":"2015","journal-title":"Drug Discov. Today"},{"issue":"3","key":"10.1016\/j.bcp.2026.118115_b0130","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1113\/jphysiol.1940.sp003850","article-title":"The substance causing renal hypertension","volume":"98","author":"Braun-Menendez","year":"1940","journal-title":"J. Physiol."},{"issue":"4","key":"10.1016\/j.bcp.2026.118115_b0135","doi-asserted-by":"crossref","first-page":"260","DOI":"10.2459\/JCM.0b013e3283356607","article-title":"A cornerstone in the history of hypertension: the seventieth anniversary of the discovery of angiotensin","volume":"11","author":"Milei","year":"2010","journal-title":"J. Cardiovasc. Med. (Hagerstown)"},{"issue":"6","key":"10.1016\/j.bcp.2026.118115_b0140","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1161\/CIRCRESAHA.116.303587","article-title":"Hypertension: renin-angiotensin-aldosterone system alterations","volume":"116","author":"Te Riet","year":"2015","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.bcp.2026.118115_b0145","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1161\/HYPERTENSIONAHA.123.19419","article-title":"Insights into the Role of angiotensin-II AT1 receptor-dependent \u03b2-arrestin signaling in cardiovascular disease","volume":"81","author":"Mathieu","year":"2024","journal-title":"Hypertension"},{"issue":"9","key":"10.1016\/j.bcp.2026.118115_b0150","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1111\/j.1440-1746.2008.05461.x","article-title":"Liver disease and the renin-angiotensin system: recent discoveries and clinical implications","volume":"23","author":"Lubel","year":"2008","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"1 Pt 2","key":"10.1016\/j.bcp.2026.118115_b0155","first-page":"H313","article-title":"Antihypertensive actions of angiotensin-(1-7) in spontaneously hypertensive rats","volume":"269","author":"Benter","year":"1995","journal-title":"Am. J. Physiol."},{"issue":"3 Pt 2","key":"10.1016\/j.bcp.2026.118115_b0160","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1161\/01.HYP.38.3.665","article-title":"Angiotensin-(1-7): cardioprotective effect in myocardial ischemia\/reperfusion","volume":"38","author":"Ferreira","year":"2001","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.bcp.2026.118115_b0165","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1161\/01.HYP.28.1.104","article-title":"Angiotensin-(1-7) inhibits vascular smooth muscle cell growth","volume":"28","author":"Freeman","year":"1996","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.bcp.2026.118115_b0170","doi-asserted-by":"crossref","first-page":"H1560","DOI":"10.1152\/ajpheart.00941.2004","article-title":"Angiotensin-(1-7) inhibits growth of cardiac myocytes through activation of the mas receptor","volume":"289","author":"Tallant","year":"2005","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"6","key":"10.1016\/j.bcp.2026.118115_b0175","doi-asserted-by":"crossref","first-page":"H2356","DOI":"10.1152\/ajpheart.00317.2005","article-title":"Angiotensin-(1-7) binds to specific receptors on cardiac fibroblasts to initiate antifibrotic and antitrophic effects","volume":"289","author":"Iwata","year":"2005","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"2","key":"10.1016\/j.bcp.2026.118115_b0180","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.critrevonc.2013.08.011","article-title":"A review of the profile of endothelin axis in cancer and its management","volume":"89","author":"Irani","year":"2014","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118115_b0185","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1177\/1358863X9700200106","article-title":"The endothelin system in cardiovascular physiology and pathophysiology","volume":"2","author":"Parris","year":"1997","journal-title":"Vasc. Med."},{"issue":"6163","key":"10.1016\/j.bcp.2026.118115_b0190","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/332411a0","article-title":"A novel potent vasoconstrictor peptide produced by vascular endothelial cells","volume":"332","author":"Yanagisawa","year":"1988","journal-title":"Nature"},{"issue":"14","key":"10.1016\/j.bcp.2026.118115_b0195","doi-asserted-by":"crossref","first-page":"11295","DOI":"10.3390\/ijms241411295","article-title":"Endothelin-1 in health and disease","volume":"24","author":"Banecki","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.bcp.2026.118115_b0200","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.semnephrol.2015.02.002","article-title":"Endothelin receptors and their antagonists","volume":"35","author":"Maguire","year":"2015","journal-title":"Semin. Nephrol."},{"issue":"9","key":"10.1016\/j.bcp.2026.118115_b0205","first-page":"986","article-title":"The causal relationship between endothelin-1 and hypertension: focusing on endothelial dysfunction, arterial stiffness, vascular remodeling, and blood pressure regulation","volume":"11","author":"Kostov","year":"2021","journal-title":"Life (basel)"},{"key":"10.1016\/j.bcp.2026.118115_b0210","article-title":"Quantifying the integrated physiological effects of endothelin-1 on cardiovascular and renal function in healthy subjects: a mathematical modeling analysis","volume":"15","author":"Yu","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bcp.2026.118115_b0215","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.693099","article-title":"Molecular signaling mechanisms and function of natriuretic peptide receptor-a in the pathophysiology of cardiovascular homeostasis","volume":"12","author":"Pandey","year":"2021","journal-title":"Front. Physiol."},{"issue":"7","key":"10.1016\/j.bcp.2026.118115_b0220","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1507\/endocrj.K10E-150","article-title":"Regulation and significance of atrial and brain natriuretic peptides as cardiac hormones","volume":"57","author":"Kuwahara","year":"2010","journal-title":"Endocr. J."},{"issue":"2","key":"10.1016\/j.bcp.2026.118115_b0225","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2169\/internalmedicine.52.8704","article-title":"Determination of the B-type natriuretic peptide level as a criterion for abnormalities in Japanese individuals in routine clinical practice: the J-ABS Multi-Center Study (Japan Abnormal BNP Standard)","volume":"52","author":"Kawai","year":"2013","journal-title":"Intern. Med."},{"key":"10.1016\/j.bcp.2026.118115_b0230","article-title":"Guanylyl cyclase\/natriuretic peptide receptor-a: identification, molecular characterization, and physiological genomics","volume":"15","author":"Pandey","year":"2022","journal-title":"Front. Mol. Neurosci."},{"issue":"4","key":"10.1016\/j.bcp.2026.118115_b0235","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.3390\/ijms19041006","article-title":"Particulate Guanylyl Cyclase A\/cGMP signaling pathway in the kidney: physiologic and therapeutic indications","volume":"19","author":"Chen","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.bcp.2026.118115_b0240","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.tips.2015.06.002","article-title":"Apelin, Elabela\/Toddler, and biased agonists as novel therapeutic agents in the cardiovascular system","volume":"36","author":"Yang","year":"2015","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bcp.2026.118115_b0245","doi-asserted-by":"crossref","unstructured":"C. Read, D. Nyimanu, T.L. Williams, D.J. Huggins, P. Sulentic, R.G.C. Macrae, P. Yang, R.C. Glen, J.J. Maguire, A.P. Davenport, International Union of Basic and Clinical Pharmacology. CVII. Structure and Pharmacology of the Apelin Receptor with a Recommendation that Elabela\/Toddler Is a Second Endogenous Peptide Ligand, Pharmacol Rev 71(4) (2019) 467-502.","DOI":"10.1124\/pr.119.017533"},{"issue":"1\u20132","key":"10.1016\/j.bcp.2026.118115_b0250","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0378-1119(93)90495-O","article-title":"A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11","volume":"136","author":"O'Dowd","year":"1993","journal-title":"Gene"},{"issue":"2","key":"10.1016\/j.bcp.2026.118115_b0255","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1006\/bbrc.1998.9489","article-title":"Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor","volume":"251","author":"Tatemoto","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.bcp.2026.118115_b0260","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1046\/j.1471-4159.2000.0740034.x","article-title":"Characterization of apelin, the ligand for the APJ receptor","volume":"74","author":"Lee","year":"2000","journal-title":"J. Neurochem."},{"issue":"17","key":"10.1016\/j.bcp.2026.118115_b0265","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1093\/cvr\/cvad171","article-title":"Targeting the apelin system for the treatment of cardiovascular diseases","volume":"119","author":"Chapman","year":"2023","journal-title":"Cardiovasc. Res."},{"issue":"12","key":"10.1016\/j.bcp.2026.118115_b0270","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/s41581-021-00461-z","article-title":"The therapeutic potential of apelin in kidney disease","volume":"17","author":"Chapman","year":"2021","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.bcp.2026.118115_b0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2021.170697","article-title":"Apelin pathway in cardiovascular, kidney, and metabolic diseases: therapeutic role of apelin analogs and apelin receptor agonists","volume":"147","author":"de Oliveira","year":"2022","journal-title":"Peptides"},{"issue":"3","key":"10.1016\/j.bcp.2026.118115_b0280","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.regpep.2003.11.002","article-title":"Immunocytochemical localization of the endogenous vasoactive peptide apelin to human vascular and endocardial endothelial cells","volume":"118","author":"Kleinz","year":"2004","journal-title":"Regul. Pept."},{"issue":"3","key":"10.1016\/j.bcp.2026.118115_b0285","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1161\/HYPERTENSIONAHA.109.134619","article-title":"[Pyr1]apelin-13 identified as the predominant apelin isoform in the human heart: vasoactive mechanisms and inotropic action in disease","volume":"54","author":"Maguire","year":"2009","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.bcp.2026.118115_b0290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ab.2013.07.006","article-title":"Pyroglutamyl apelin-13 identified as the major apelin isoform in human plasma","volume":"442","author":"Zhen","year":"2013","journal-title":"Anal. Biochem."},{"issue":"6","key":"10.1016\/j.bcp.2026.118115_b0295","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.devcel.2013.11.002","article-title":"ELABELA: a hormone essential for heart development signals via the apelin receptor","volume":"27","author":"Chng","year":"2013","journal-title":"Dev. Cell"},{"key":"10.1016\/j.bcp.2026.118115_b0300","doi-asserted-by":"crossref","first-page":"8170","DOI":"10.1038\/srep08170","article-title":"Elabela-apelin receptor signaling pathway is functional in mammalian systems","volume":"5","author":"Wang","year":"2015","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.bcp.2026.118115_b0305","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s00395-015-0521-6","article-title":"Characterization of apela, a novel endogenous ligand of apelin receptor, in the adult heart","volume":"111","author":"Perj\u00e9s","year":"2016","journal-title":"Basic Res. Cardiol."},{"issue":"12","key":"10.1016\/j.bcp.2026.118115_b0310","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1161\/CIRCULATIONAHA.116.023218","article-title":"Elabela\/toddler is an endogenous agonist of the apelin APJ receptor in the adult cardiovascular system, and exogenous administration of the peptide compensates for the downregulation of its expression in pulmonary arterial hypertension","volume":"135","author":"Yang","year":"2017","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.bcp.2026.118115_b0315","first-page":"3343","article-title":"Apelin signaling antagonizes Ang II effects in mouse models of atherosclerosis","volume":"118","author":"Chun","year":"2008","journal-title":"J. Clin. Invest."},{"issue":"22","key":"10.1016\/j.bcp.2026.118115_b0320","doi-asserted-by":"crossref","first-page":"4443","DOI":"10.1038\/sj.emboj.7600422","article-title":"NO activation of guanylyl cyclase","volume":"23","author":"Russwurm","year":"2004","journal-title":"EMBO J."},{"issue":"1","key":"10.1016\/j.bcp.2026.118115_b0325","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/s42003-022-03140-2","article-title":"PDGF regulates guanylate cyclase expression and cGMP signaling in vascular smooth muscle","volume":"5","author":"Hildebrand","year":"2022","journal-title":"Commun. Biol."},{"issue":"1\u20133","key":"10.1016\/j.bcp.2026.118115_b0330","first-page":"129","article-title":"Towards an understanding of the mechanism of action of cyclic AMP and cyclic GMP in smooth muscle relaxation","volume":"28","author":"Lincoln","year":"1991","journal-title":"Blood Vessels"},{"issue":"5444","key":"10.1016\/j.bcp.2026.118115_b0335","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1126\/science.286.5444.1583","article-title":"Regulation of myosin phosphatase by a specific interaction with cGMP- dependent protein kinase Ialpha","volume":"286","author":"Surks","year":"1999","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.bcp.2026.118115_b0340","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1161\/CIRCRESAHA.107.153981","article-title":"cGMP-dependent relaxation of smooth muscle is coupled with the change in the phosphorylation of myosin phosphatase","volume":"101","author":"Nakamura","year":"2007","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.bcp.2026.118115_b0345","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1152\/physrev.00015.2005","article-title":"Function of cGMP-dependent protein kinases as revealed by gene deletion","volume":"86","author":"Hofmann","year":"2006","journal-title":"Physiol. Rev."},{"issue":"4","key":"10.1016\/j.bcp.2026.118115_b0350","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1161\/CIRCRESAHA.108.179333","article-title":"Hypoxia-induced apelin expression regulates endothelial cell proliferation and regenerative angiogenesis","volume":"103","author":"Eyries","year":"2008","journal-title":"Circ. Res."},{"issue":"44","key":"10.1016\/j.bcp.2026.118115_b0355","doi-asserted-by":"crossref","first-page":"14878","DOI":"10.1074\/jbc.RA120.013834","article-title":"Angiotensin AT1 receptor antagonism by losartan stimulates adipocyte browning via induction of apelin","volume":"295","author":"Kim","year":"2020","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.bcp.2026.118115_b0360","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1111\/j.1476-5381.2012.02192.x","article-title":"The apelin receptor inhibits the angiotensin II type 1 receptor via allosteric trans-inhibition","volume":"168","author":"Siddiquee","year":"2013","journal-title":"Br. J. Pharmacol."},{"issue":"7","key":"10.1016\/j.bcp.2026.118115_b0365","doi-asserted-by":"crossref","first-page":"550","DOI":"10.3109\/10641963.2013.764889","article-title":"Apelin effects on blood pressure and RAS in DOCA-salt-induced hypertensive rats","volume":"35","author":"Akc\u0131lar","year":"2013","journal-title":"Clin. Exp. Hypertens."},{"issue":"4","key":"10.1016\/j.bcp.2026.118115_b0370","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/jb\/mvaa129","article-title":"The apelin\/APJ system in the regulation of vascular tone: friend or foe?","volume":"169","author":"Rikitake","year":"2021","journal-title":"J. Biochem."},{"issue":"5","key":"10.1016\/j.bcp.2026.118115_b0375","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/jb\/mvz071","article-title":"Cooperative action of APJ and \u03b11A-adrenergic receptor in vascular smooth muscle cells induces vasoconstriction","volume":"166","author":"Nagano","year":"2019","journal-title":"J. Biochem."},{"issue":"5","key":"10.1016\/j.bcp.2026.118115_b0380","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1161\/01.RES.0000033522.37861.69","article-title":"Apelin, the novel endogenous ligand of the orphan receptor APJ, regulates cardiac contractility","volume":"91","author":"Szokodi","year":"2002","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.bcp.2026.118115_b0385","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.cardiores.2004.08.018","article-title":"The endogenous peptide apelin potently improves cardiac contractility and reduces cardiac loading in vivo","volume":"65","author":"Ashley","year":"2005","journal-title":"Cardiovasc. Res."},{"issue":"7411","key":"10.1016\/j.bcp.2026.118115_b0390","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/nature11263","article-title":"APJ acts as a dual receptor in cardiac hypertrophy","volume":"488","author":"Scimia","year":"2012","journal-title":"Nature"},{"issue":"6172","key":"10.1016\/j.bcp.2026.118115_b0395","doi-asserted-by":"crossref","DOI":"10.1126\/science.1248636","article-title":"Toddler: an embryonic signal that promotes cell movement via Apelin receptors","volume":"343","author":"Pauli","year":"2014","journal-title":"Science"},{"issue":"30","key":"10.1016\/j.bcp.2026.118115_b0400","doi-asserted-by":"crossref","first-page":"18261","DOI":"10.1074\/jbc.M115.648238","article-title":"Apela regulates fluid homeostasis by binding to the APJ receptor to activate Gi signaling","volume":"290","author":"Deng","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.bcp.2026.118115_b0405","article-title":"Expression and functional implications of the renal apelinergic system in rodents","volume":"12","author":"O'Carroll","year":"2017","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.bcp.2026.118115_b0410","doi-asserted-by":"crossref","first-page":"F1122","DOI":"10.1152\/ajprenal.00606.2019","article-title":"ELABELA antagonizes intrarenal renin-angiotensin system to lower blood pressure and protects against renal injury","volume":"318","author":"Xu","year":"2020","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"10","key":"10.1016\/j.bcp.2026.118115_b0415","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1038\/s41401-022-00875-w","article-title":"Chronic infusion of ELABELA alleviates vascular remodeling in spontaneously hypertensive rats via anti-inflammatory, anti-oxidative and anti-proliferative effects","volume":"43","author":"Ye","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.bcp.2026.118115_b0420","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2025.1623215","article-title":"ELABELA: a polypeptide with therapeutic potential in cardiovascular diseases","volume":"12","author":"Yan","year":"2025","journal-title":"Front. Cardiovasc. Med."},{"issue":"8","key":"10.1016\/j.bcp.2026.118115_b0425","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/s41419-020-02912-0","article-title":"ELABELA attenuates deoxycorticosterone acetate\/salt-induced hypertension and renal injury by inhibition of NADPH oxidase\/ROS\/NLRP3 inflammasome pathway","volume":"11","author":"Chen","year":"2020","journal-title":"Cell Death Dis."},{"issue":"31","key":"10.1016\/j.bcp.2026.118115_b0430","doi-asserted-by":"crossref","first-page":"3622","DOI":"10.2174\/138161209789271834","article-title":"Angiotensin converting enzyme (ACE) inhibitory peptides: production and implementation of functional food","volume":"15","author":"De Leo","year":"2009","journal-title":"Curr. Pharm. Des."},{"issue":"3","key":"10.1016\/j.bcp.2026.118115_b0435","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.3390\/ijms25031391","article-title":"Exploring the potential of bioactive peptides: from natural sources to therapeutics","volume":"25","author":"Purohit","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2026.118115_b0440","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3390\/nu17010097","article-title":"Research progress of food-derived antihypertensive peptides in regulating the key factors of the renin-angiotensin system","volume":"17","author":"Yao","year":"2024","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.bcp.2026.118115_b0445","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3390\/md23020081","article-title":"Screening of potential angiotensin-converting enzyme-inhibitory peptides in squid (Todarodes pacificus) skin hydrolysates: preliminary study of its mechanism of inhibition","volume":"23","author":"Li","year":"2025","journal-title":"Mar. Drugs"},{"issue":"24","key":"10.1016\/j.bcp.2026.118115_b0450","doi-asserted-by":"crossref","first-page":"4818","DOI":"10.3390\/molecules30244818","article-title":"Identification, molecular docking mechanism and cellular activity of selenium-enriched ACE inhibitory peptides from oysters","volume":"30","author":"Yue","year":"2025","journal-title":"Molecules"},{"issue":"9","key":"10.1016\/j.bcp.2026.118115_b0455","doi-asserted-by":"crossref","first-page":"410","DOI":"10.3390\/toxins16090410","article-title":"Identification of new angiotensin-converting enzyme inhibitory peptides isolated from the hydrolysate of the venom of Nemopilema nomurai jellyfish","volume":"16","author":"Mohan Prakash","year":"2024","journal-title":"Toxins (basel)"},{"issue":"1","key":"10.1016\/j.bcp.2026.118115_b0460","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3390\/foods15010084","article-title":"Novel ACE-inhibitory peptides from royal jelly proteins: comprehensive screening, mechanistic insights, and endothelial protection","volume":"15","author":"Yang","year":"2025","journal-title":"Foods"},{"issue":"3","key":"10.1016\/j.bcp.2026.118115_b0465","doi-asserted-by":"crossref","first-page":"653","DOI":"10.3390\/nu12030653","article-title":"Efficacy of a novel ACE-inhibitory peptide from Sargassum Maclurei in hypertension and reduction of intracellular endothelin-1","volume":"12","author":"Zheng","year":"2020","journal-title":"Nutrients"},{"issue":"23","key":"10.1016\/j.bcp.2026.118115_b0470","doi-asserted-by":"crossref","first-page":"14850","DOI":"10.3390\/ijms232314850","article-title":"Screening and molecular mechanisms of novel ACE-inhibitory peptides from Gracilariopsis lemaneiformis","volume":"23","author":"Su","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2026.118115_b0475","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s43014-023-00132-5","article-title":"An overview on the nutritional and bioactive components of green seaweeds","volume":"5","author":"Xu","year":"2023","journal-title":"Food Prod. Process. Nutr."},{"issue":"4","key":"10.1016\/j.bcp.2026.118115_b0480","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1161\/HYPERTENSIONAHA.118.12012","article-title":"Design, synthesis, and actions of an innovative bispecific designer peptide","volume":"73","author":"Meems","year":"2019","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.bcp.2026.118115_b0485","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1161\/HYPERTENSIONAHA.124.23579","article-title":"NPA7: a dual receptor activating peptide that inhibits cardiac oxidative stress","volume":"82","author":"Ma","year":"2025","journal-title":"Hypertension"},{"issue":"14","key":"10.1016\/j.bcp.2026.118115_b0490","doi-asserted-by":"crossref","first-page":"8258","DOI":"10.1073\/pnas.1432869100","article-title":"Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas","volume":"100","author":"Santos","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.bcp.2026.118115_b0495","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1161\/01.HYP.0000251865.35728.2f","article-title":"Angiotensin-(1-7) through receptor Mas mediates endothelial nitric oxide synthase activation via Akt-dependent pathways","volume":"49","author":"Sampaio","year":"2007","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.bcp.2026.118115_b0500","doi-asserted-by":"crossref","first-page":"H958","DOI":"10.1152\/ajpheart.00723.2018","article-title":"The renin-angiotensin system: going beyond the classical paradigms","volume":"316","author":"Santos","year":"2019","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"6","key":"10.1016\/j.bcp.2026.118115_b0505","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1161\/HYPERTENSIONAHA.106.084848","article-title":"Angiotensin-(1-7) counterregulates angiotensin II signaling in human endothelial cells","volume":"50","author":"Sampaio","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.bcp.2026.118115_b0510","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3389\/fnmol.2014.00075","article-title":"Guanylyl cyclase\/natriuretic peptide receptor-a signaling antagonizes phosphoinositide hydrolysis, Ca2+ release, and activation of protein kinase C","volume":"7","author":"Pandey","year":"2014","journal-title":"Front. Mol. Neurosci."},{"issue":"4","key":"10.1016\/j.bcp.2026.118115_b0515","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1161\/HYPERTENSIONAHA.114.05099","article-title":"Design, characterization, and first-in-human study of the vascular actions of a novel biased apelin receptor agonist","volume":"65","author":"Brame","year":"2015","journal-title":"Hypertension"},{"issue":"9","key":"10.1016\/j.bcp.2026.118115_b0520","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1111\/bph.14603","article-title":"A novel cyclic biased agonist of the apelin receptor, MM07, is disease modifying in the rat monocrotaline model of pulmonary arterial hypertension","volume":"176","author":"Yang","year":"2019","journal-title":"Br. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.bcp.2026.118115_b0525","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/j.cell.2024.02.004","article-title":"Structure-based design of non-hypertrophic apelin receptor modulator","volume":"187","author":"Wang","year":"2024","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.bcp.2026.118115_b0530","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1161\/01.HYP.31.1.64","article-title":"Dissociation between muscle and skin sympathetic nerve activity in essential hypertension, obesity, and congestive heart failure","volume":"31","author":"Grassi","year":"1998","journal-title":"Hypertension"},{"issue":"6 Pt 2","key":"10.1016\/j.bcp.2026.118115_b0535","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1161\/01.HYP.13.6.870","article-title":"Age-related changes in muscle sympathetic nerve activity in essential hypertension","volume":"13","author":"Yamada","year":"1989","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.bcp.2026.118115_b0540","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1161\/HYPERTENSIONAHA.111.00633","article-title":"Sympathetic nervous system and hypertension","volume":"61","author":"DiBona","year":"2013","journal-title":"Hypertension"},{"issue":"10","key":"10.1016\/j.bcp.2026.118115_b0545","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s11906-023-01254-4","article-title":"Sympathetic neural mechanisms in hypertension: recent insights","volume":"25","author":"Grassi","year":"2023","journal-title":"Curr. Hypertens. Rep."},{"issue":"1\u20132","key":"10.1016\/j.bcp.2026.118115_b0550","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0006-8993(98)00587-3","article-title":"Neurons in the hypothalamic paraventricular nucleus send collaterals to the spinal cord and to the rostral ventrolateral medulla in the rat","volume":"801","author":"Shafton","year":"1998","journal-title":"Brain Res."},{"issue":"3","key":"10.1016\/j.bcp.2026.118115_b0555","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S0306-4522(98)00255-3","article-title":"Identification of an efferent projection from the paraventricular nucleus of the hypothalamus terminating close to spinally projecting rostral ventrolateral medullary neurons","volume":"88","author":"Pyner","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.bcp.2026.118115_b0560","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2022.858941","article-title":"The paraventricular nucleus of the hypothalamus in control of blood pressure and blood pressure variability","volume":"13","author":"Savi\u0107","year":"2022","journal-title":"Front. Physiol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118115_b0565","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s12264-018-0316-5","article-title":"Impaired hypothalamic regulation of sympathetic outflow in primary hypertension","volume":"35","author":"Zhou","year":"2019","journal-title":"Neurosci. Bull."},{"issue":"12","key":"10.1016\/j.bcp.2026.118115_b0570","doi-asserted-by":"crossref","first-page":"6270","DOI":"10.1073\/pnas.76.12.6270","article-title":"Calcineurin: a calcium- and calmodulin-binding protein of the nervous system","volume":"76","author":"Klee","year":"1979","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"9","key":"10.1016\/j.bcp.2026.118115_b0575","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1101\/lm.027201.112","article-title":"Neural functions of calcineurin in synaptic plasticity and memory","volume":"19","author":"Baumg\u00e4rtel","year":"2012","journal-title":"Learn. Mem."},{"issue":"8","key":"10.1016\/j.bcp.2026.118115_b0580","first-page":"671","article-title":"Regulator of calcineurin (RCAN): beyond down syndrome critical region","volume":"43","author":"Lee","year":"2020","journal-title":"Mol. Cells"},{"issue":"6477","key":"10.1016\/j.bcp.2026.118115_b0585","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/369235a0","article-title":"Regulation of NMDA channel function by endogenous Ca2+-dependent phosphatase","volume":"369","author":"Lieberman","year":"1994","journal-title":"Nature"},{"issue":"5203","key":"10.1016\/j.bcp.2026.118115_b0590","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1126\/science.7878472","article-title":"Synaptic desensitization of NMDA receptors by calcineurin","volume":"267","author":"Tong","year":"1995","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.bcp.2026.118115_b0595","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1113\/jphysiol.2013.263814","article-title":"Calcineurin inhibitor induces pain hypersensitivity by potentiating pre- and postsynaptic NMDA receptor activity in spinal cords","volume":"592","author":"Chen","year":"2014","journal-title":"J. Physiol."},{"issue":"4","key":"10.1016\/j.bcp.2026.118115_b0600","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1161\/CIRCRESAHA.122.320976","article-title":"Calcineurin controls hypothalamic NMDA receptor activity and sympathetic outflow","volume":"131","author":"Zhou","year":"2022","journal-title":"Circ. Res."},{"issue":"7","key":"10.1016\/j.bcp.2026.118115_b0605","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1161\/CIRCRESAHA.123.322562","article-title":"Brain \u03b12\u03b4-1-bound NMDA receptors drive calcineurin inhibitor-induced hypertension","volume":"133","author":"Zhou","year":"2023","journal-title":"Circ. Res."},{"issue":"3","key":"10.1016\/j.bcp.2026.118115_b0610","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1161\/CIRCRESAHA.124.325975","article-title":"RCAN1-mediated Calcineurin impairment drives sympathetic outflow in hypertension","volume":"137","author":"Zhou","year":"2025","journal-title":"Circ. Res."},{"issue":"27","key":"10.1016\/j.bcp.2026.118115_b0615","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aba3681","article-title":"The structure of the RCAN1:CN complex explains the inhibition of and substrate recruitment by calcineurin","volume":"6","author":"Li","year":"2020","journal-title":"Sci. Adv."},{"issue":"37","key":"10.1016\/j.bcp.2026.118115_b0620","doi-asserted-by":"crossref","first-page":"13075","DOI":"10.1073\/pnas.0503846102","article-title":"Identification of a peptide fragment of DSCR1 that competitively inhibits calcineurin activity in vitro and in vivo","volume":"102","author":"Chan","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcp.2026.118115_b0625","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/B978-0-12-394311-8.00019-4","article-title":"Afadin\/AF-6 and canoe: roles in cell adhesion and beyond","volume":"116","author":"Mandai","year":"2013","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"issue":"6","key":"10.1016\/j.bcp.2026.118115_b0630","doi-asserted-by":"crossref","first-page":"621","DOI":"10.2183\/pjab.86.621","article-title":"Cell adhesion molecules nectins and associating proteins: implications for physiology and pathology","volume":"86","author":"Ogita","year":"2010","journal-title":"Proc. Jpn. Acad. Ser. B Phys. Biol. Sci."},{"issue":"4","key":"10.1016\/j.bcp.2026.118115_b0635","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.bbrc.2009.05.097","article-title":"Involvement of afadin in the formation and remodeling of synapses in the hippocampus","volume":"385","author":"Majima","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.bcp.2026.118115_b0640","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1523\/JNEUROSCI.4565-11.2012","article-title":"Afadin, a Ras\/Rap effector that controls cadherin function, promotes spine and excitatory synapse density in the hippocampus","volume":"32","author":"Beaudoin","year":"2012","journal-title":"J. Neurosci."},{"issue":"10","key":"10.1016\/j.bcp.2026.118115_b0645","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0110549","article-title":"Genetic ablation of afadin causes mislocalization and deformation of Paneth cells in the mouse small intestinal epithelium","volume":"9","author":"Tanaka-Okamoto","year":"2014","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.bcp.2026.118115_b0650","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0080356","article-title":"Genetic deletion of afadin causes hydrocephalus by destruction of adherens junctions in radial glial and ependymal cells in the midbrain","volume":"8","author":"Yamamoto","year":"2013","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.bcp.2026.118115_b0655","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1161\/ATVBAHA.125.322619","article-title":"Afadin promotes vascular smooth muscle cell contraction by interacting with phospholipase C to enhance Ca2+ signaling for blood pressure regulation","volume":"45","author":"Khan","year":"2025","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118115_b0660","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1038\/s41467-020-14867-z","article-title":"B38-CAP is a bacteria-derived ACE2-like enzyme that suppresses hypertension and cardiac dysfunction","volume":"11","author":"Minato","year":"2020","journal-title":"Nat. Commun."},{"issue":"26","key":"10.1016\/j.bcp.2026.118115_b0665","doi-asserted-by":"crossref","first-page":"8299","DOI":"10.1021\/bi9904959","article-title":"The HELLGH motif of rat liver dipeptidyl peptidase III is involved in zinc coordination and the catalytic activity of the enzyme","volume":"38","author":"Fukasawa","year":"1999","journal-title":"Biochemistry"},{"issue":"12","key":"10.1016\/j.bcp.2026.118115_b0670","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1515\/BC.1999.182","article-title":"Dipeptidyl peptidase III from rat liver cytosol: purification, molecular cloning and immunohistochemical localization","volume":"380","author":"Ohkubo","year":"1999","journal-title":"Biol. Chem."},{"issue":"18","key":"10.1016\/j.bcp.2026.118115_b0675","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1111\/j.1742-4658.2011.08275.x","article-title":"Dipeptidyl peptidase III: a multifaceted oligopeptide N-end cutter","volume":"278","author":"Prajapati","year":"2011","journal-title":"FEBS J."},{"issue":"12","key":"10.1016\/j.bcp.2026.118115_b0680","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1515\/BC.2000.151","article-title":"Human and rat dipeptidyl peptidase III: biochemical and mass spectrometric arguments for similarities and differences","volume":"381","author":"Abrami\u0107","year":"2000","journal-title":"Biol. Chem."},{"issue":"8","key":"10.1016\/j.bcp.2026.118115_b0685","doi-asserted-by":"crossref","first-page":"843","DOI":"10.2174\/1389203718666170329104936","article-title":"Pathophysiological implications of dipeptidyl peptidases","volume":"18","author":"Sato","year":"2017","journal-title":"Curr. Protein Pept. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2026.118115_b0690","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1515\/bchm3.1988.369.1.29","article-title":"Dipeptidyl peptidase III from human erythrocytes","volume":"369","author":"Abrami\u0107","year":"1988","journal-title":"Biol. Chem. Hoppe Seyler"},{"issue":"3","key":"10.1016\/j.bcp.2026.118115_b0695","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1161\/HYPERTENSIONAHA.116.07357","article-title":"Novel therapeutic role for dipeptidyl peptidase III in the treatment of hypertension","volume":"68","author":"Pang","year":"2016","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.bcp.2026.118115_b0700","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/00000441-200307000-00003","article-title":"The renin-angiotensin-aldosterone system: cardiorenal effects and implications for renal and cardiovascular disease states","volume":"326","author":"Brewster","year":"2003","journal-title":"Am. J. Med. Sci."},{"issue":"4","key":"10.1016\/j.bcp.2026.118115_b0705","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/hr.2009.5","article-title":"Inhibition of the renin-angiotensin system and target organ protection","volume":"32","author":"Iwanami","year":"2009","journal-title":"Hypertens. Res."},{"issue":"1 Suppl","key":"10.1016\/j.bcp.2026.118115_b0710","doi-asserted-by":"crossref","first-page":"30A","DOI":"10.1016\/j.amjcard.2009.10.009","article-title":"Renin-angiotensin system blockade and cardiovascular and renal protection","volume":"105","author":"Hoogwerf","year":"2010","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.bcp.2026.118115_b0715","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100761","article-title":"Cardio- and reno-protective effects of dipeptidyl peptidase III in diabetic mice","volume":"296","author":"Komeno","year":"2021","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.bcp.2026.118115_b0720","first-page":"910","article-title":"Effects of an analogue of angiotensin II, [Sar1,Ile8] ATII, on blood pressure, plasma renin activity and plasma aldosterone in various forms of hypertension","volume":"53","author":"Yamamoto","year":"1977","journal-title":"Nihon Naibunpi Gakkai Zasshi"},{"issue":"2","key":"10.1016\/j.bcp.2026.118115_b0725","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1291\/hypres.22.147","article-title":"Angiotensin II receptor antagonists: an emerging new class of cardiovascular therapeutics","volume":"22","author":"Timmermans","year":"1999","journal-title":"Hypertens. Res."},{"issue":"3","key":"10.1016\/j.bcp.2026.118115_b0730","doi-asserted-by":"crossref","first-page":"618","DOI":"10.3390\/molecules26030618","article-title":"From angiotensin II to cyclic peptides and angiotensin receptor blockers (ARBs): perspectives of ARBs in COVID-19 therapy","volume":"26","author":"Matsoukas","year":"2021","journal-title":"Molecules"},{"issue":"6","key":"10.1016\/j.bcp.2026.118115_b0735","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/S0026-895X(25)09255-7","article-title":"Different types of receptor interaction of peptide and nonpeptide angiotensin II antagonists revealed by receptor binding and functional studies","volume":"41","author":"Wienen","year":"1992","journal-title":"Mol. Pharmacol."},{"issue":"6","key":"10.1016\/j.bcp.2026.118115_b0740","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1161\/HYPERTENSIONAHA.121.17159","article-title":"First-in-human study of MANP: a Novel ANP (atrial natriuretic peptide) analog in human hypertension","volume":"78","author":"Chen","year":"2021","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.bcp.2026.118115_b0745","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jacbts.2023.08.011","article-title":"MANP in hypertension with metabolicsyndrome: proof-of-concept study of natriuretic peptide-based therapyfor cardiometabolic disease","volume":"9","author":"Ma","year":"2024","journal-title":"JACC Basic Transl Sci"},{"issue":"3","key":"10.1016\/j.bcp.2026.118115_b0750","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1161\/CIRCHEARTFAILURE.111.000077","article-title":"Sustained cardiovascular actions of APJ agonism during renin-angiotensin system activation and in patients with heart failure","volume":"6","author":"Barnes","year":"2013","journal-title":"Circ. Heart Fail."},{"issue":"11","key":"10.1016\/j.bcp.2026.118115_b0755","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1021\/acsptsci.4c00503","article-title":"Comparison of protocols to test peptide stability in blood plasma and cell culture supernatants","volume":"7","author":"Kohler","year":"2024","journal-title":"ACS Pharmacol. Transl. Sci."},{"issue":"10","key":"10.1016\/j.bcp.2026.118115_b0760","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.3390\/ph15101283","article-title":"Strategies for improving peptide stability and delivery","volume":"15","author":"Al Musaimi","year":"2022","journal-title":"Pharmaceuticals (Basel)"},{"issue":"7","key":"10.1016\/j.bcp.2026.118115_b0765","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1021\/acs.joc.3c01494","article-title":"Process mass intensity (PMI): a holistic analysis of current peptide manufacturing processes informs sustainability in peptide synthesis","volume":"89","author":"Kekessie","year":"2024","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.bcp.2026.118115_b0770","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1608401","article-title":"Immunogenicity of therapeutic peptide products: bridging the gaps regarding the role of product-related risk factors","volume":"16","author":"Puig","year":"2025","journal-title":"Front. Immunol."},{"issue":"27","key":"10.1016\/j.bcp.2026.118115_b0775","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1093\/eurheartj\/ehaf444","article-title":"Hot topics in prevention: resistant hypertension, blood pressure variability, triglycerides, and apoB-containing lipoproteins","volume":"46","author":"Crea","year":"2025","journal-title":"Eur. Heart J."},{"issue":"5","key":"10.1016\/j.bcp.2026.118115_b0780","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s40292-019-00339-z","article-title":"Blood pressure variability and therapeutic implications in hypertension and cardiovascular diseases","volume":"26","author":"Nardin","year":"2019","journal-title":"High Blood Press Cardiovasc Prev."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226004508?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226004508?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T05:30:23Z","timestamp":1783920623000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295226004508"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":156,"alternative-id":["S0006295226004508"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118115","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic development for hypertension by targeting the peptide-mediated blood pressure control","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118115","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118115"}}